ArticleJournal of neuro-oncology2025
Prognostic value of hypertension timing for survival in glioblastoma patients receiving bevacizumab: a retrospective single centre analysis.
Irfan Kesumayadi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.